Showing results (1-10 of 95) with videos related to
Sort By:
Pageof 10
Therapeutic Advances in Hematology|April 5, 2013
When the Brakes are Lost: LNK Dysfunction in Mice, Men, and Myeloproliferative NeoplasmsStephen T OhExpert Review of Hematology|November 19, 2010
JAK2 V617F and beyond: role of genetics and aberrant signaling in the pathogenesis of myeloproliferative neoplasmsStephen T Oh, Jason GotlibBest Practice & Research. Clinical Haematology|September 6, 2014
Prognostication in MF: from CBC to cytogenetics to molecular markersAmy Zhou, Stephen T OhCurrent Hematologic Malignancy Reports|April 29, 2010
Antiangiogenic therapy in myelodysplastic syndromes: is there a role?Stephen T Oh, Jason GotlibAmerican Journal of Clinical Pathology|June 19, 2012
Pathology consultation on myeloproliferative neoplasmsAmy E Schmidt, Stephen T Oh, Therapeutic Advances in Hematology|March 2, 2017
Splanchnic vein thrombosis in myeloproliferative neoplasms: pathophysiology and molecular mechanisms of diseaseJoan How, Amy Zhou, Stephen T OhCurrent Hematologic Malignancy Reports|September 27, 2017
Prognostication in Philadelphia Chromosome Negative Myeloproliferative Neoplasms: a Review of the Recent LiteratureAmy Zhou, Amber Afzal, Stephen T OhCancer Discovery|March 5, 2020
Unraveling the Architecture of Classic Hodgkin Lymphoma One Cell at a TimeDaniel A C Fisher, Stephen T OhJournal of Virology|February 14, 2004
Roles of the E6 and E7 proteins in the life cycle of low-risk human papillomavirus type 11Stephen T Oh, Michelle S Longworth, Laimonis A LaiminsMethods in Molecular Biology (Clifton, N.J.)|July 22, 2017
Analysis of Signaling Networks at the Single-Cell Level Using Mass CytometryShovik Bandyopadhyay, Daniel A C Fisher, Olga Malkova, et al.Pageof 10